Literature DB >> 2827591

Increased prevalence of late stage T cell activation antigen (VLA-1) in active juvenile chronic arthritis.

N Odum1, N Morling, P Platz, B Hofmann, L P Ryder, C Heilmann, F K Pedersen, L P Nielsen, J Friis, A Svejgaard.   

Abstract

The presence of activated T cells as judged from the reaction with monoclonal antibodies (MoAb) against (a) a late stage T cell activation antigen (VLA-1), (b) the interleukin 2 (IL2) receptor (CD25), and (c) four different HLA class II molecules (HLA-DR, DRw52, DQ, and DP) was studied in 15 patients with active juvenile chronic arthritis (JCA), 10 patients with JCA in remission, and 11 age matched, healthy controls. In addition, the distribution of T 'helper/inducer' (CD4+), T 'suppressor/inducer' (CD4+, Leu8+), T 'suppressor/cytotoxic' (CD8+), and 'natural killer' (NK) cells (CD16+) was studied. Twenty patients and six controls were investigated for the capability to stimulate alloreactivated primed lymphocytes. The prevalence of VLA-1 positive, large cells was significantly increased to 5% (median value) in active JCA as compared with JCA in remission (2%, p less than 0.05) and controls (1%, p less than 0.05), whereas no significant difference between JCA in remission and controls was observed. Except for two patients with active JCA, less than 1% IL2 receptor bearing cells were found in patients with JCA and controls. No significant difference in the prevalence and expression of the various HLA class II antigens was observed between the groups. Similarly, no significant differences in stimulatory capability in secondary mixed lymphocyte culture (MLC) were seen. The distribution of T helper/inducer (CD4+), T suppressor/cytotoxic (CD8+), and NK cells was similar in active JCA, JCA in remission, and controls. The prevalence of T suppressor/inducer (CD4+,Leu8+) cells was higher in remission JCA (17%) than in active JCA (11%) and controls (10%). This increase, however, did not reach statistical significance. In conclusion, late stage but not early stage T cell activation antigens were increased in patients with active JCA as compared with patients with JCA in remission and control, whereas some patients in remission had an increased prevalence of T suppressor/inducer cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2827591      PMCID: PMC1003404          DOI: 10.1136/ard.46.11.846

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

1.  A "new" supertypic HLA-DP related determinant detected by primed lymphocyte typing (PLT).

Authors:  N Odum; B Hofmann; J J Hyldig-Nielsen; B K Jakobsen; N Morling; P Platz; L P Ryder; A Svejgaard
Journal:  Tissue Antigens       Date:  1987-02

2.  The HLA-DP polymorphism in Denmark investigated by local and international PLT reagents. Definition of two "new" DP antigens.

Authors:  N Odum; R Hartzman; B K Jakobsen; N Morling; P Platz; F M Robbins; L P Ryder; A Svejgaard
Journal:  Tissue Antigens       Date:  1986-08

3.  Differential inhibition of HLA-D- or SB-directed secondary lymphoproliferative responses with monoclonal antibodies detecting human Ia-like determinants.

Authors:  G P Pawelec; S Shaw; A Ziegler; C Müller; P Wernet
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

4.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

5.  Detection of T and B cell antigens hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method.

Authors:  R Warnke; R Levy
Journal:  J Histochem Cytochem       Date:  1980-08       Impact factor: 2.479

6.  Studies of a human T lymphocyte antigen recognized by a monoclonal antibody.

Authors:  E G Engleman; R Warnke; R I Fox; J Dilley; C J Benike; R Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

7.  Direct evidence for loss of human suppressor cells during active autoimmune disease.

Authors:  A J Strelkauskas; R T Callery; J McDowell; Y Borel; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

8.  Communicative interactions between subpopulations of human T lymphocytes required for generation of suppressor effector function in a primary antibody response.

Authors:  C Morimoto; J A Distaso; Y Borel; S F Schlossman; E L Reinherz
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

9.  Augmented numbers of HLA-DR-positive T lymphocytes in the synovial fluid and synovial tissue of patients with rheumatoid arthritis and juvenile rheumatoid arthritis: in vivo-activated T lymphocytes are potent stimulators in the mixed lymphocyte reaction.

Authors:  O Førre; J H Dobloug; J B Natvig
Journal:  Scand J Immunol       Date:  1982-02       Impact factor: 3.487

10.  Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man.

Authors:  J A Ledbetter; R L Evans; M Lipinski; C Cunningham-Rundles; R A Good; L A Herzenberg
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Immunopathogenesis of juvenile rheumatoid arthritis: role of T cells and MHC.

Authors:  L I Sakkas; C D Platsoucas
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

2.  Synovial fluid cells in juvenile arthritis: evidence of selective T cell migration to inflamed tissue.

Authors:  E D Silverman; B Isacovics; D Petsche; R M Laxer
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

3.  Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritis.

Authors:  Jeffrey A Dvergsten; Robert G Mueller; Patricia Griffin; Sameem Abedin; Allyson Pishko; Joshua J Michel; Margalit E Rosenkranz; Ann M Reed; Daniel A Kietz; Abbe N Vallejo
Journal:  Arthritis Rheum       Date:  2013-08

4.  Aetiological role of bacteria associated with reactive arthritis in pauciarticular juvenile chronic arthritis.

Authors:  J Sieper; J Braun; E Döring; P Wu; J Heesemann; J Treharne; G Kingsley
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

5.  Expression and functions of very late antigen 1 in inflammatory joint diseases.

Authors:  I Bank; D Roth; M Book; A Guterman; I Shnirrer; R Block; M Ehrenfeld; P Langevitz; H Brenner; M Pras
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

6.  Adhesion of peripheral blood lymphocytes of children with arthritis to human umbilical vein endothelial cells.

Authors:  K Oen; G Danell; S Stewart; J Wilkins; K Tazumi; K Jacobson
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.